- Home
- SBLK vs SLNO Comparison
SBLK vs SLNO Comparison
Compare SBLK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBLK | SLNO |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SBLK | SLNO |
|---|---|---|
| Price | $24.91 | $52.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $22.00 | ★ $83.00 |
| AVG Volume (30 Days) | 968.4K | ★ 6.2M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | $11.56 | $150.46 |
| Revenue Next Year | N/A | $50.37 |
| P/E Ratio | ★ $47.06 | $135.09 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $13.92 | $29.43 |
| 52 Week High | $27.20 | $89.12 |
Technical Indicators
Market Signals| Indicator | SBLK | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 77.16 |
| Support Level | $21.71 | $48.91 |
| Resistance Level | $27.20 | $55.47 |
| Average True Range (ATR) | 0.75 | 1.00 |
| MACD | 0.11 | 0.88 |
| Stochastic Oscillator | 82.13 | 99.47 |
Price Performance
Historical ComparisonAbout SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.